↓ Skip to main content

Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, December 2013
Altmetric Badge

Readers on

mendeley
47 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control
Published in
Journal of Experimental & Clinical Cancer Research, December 2013
DOI 10.1186/1756-9966-32-103
Pubmed ID
Authors

Maria Grazia Petrongari, Valeria Landoni, Biancamaria Saracino, Sara Gomellini, Stefano Arcangeli, Giuseppe Iaccarino, Paola Pinnarò, Giorgio Arcangeli, Lidia Strigari

Abstract

To investigate the feasibility of dose escalation (86 Gy at 2 Gy/fraction) with intensity modulated radiation therapy (IMRT) in intermediate-risk prostate cancer without androgen deprivation therapy.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 2%
Unknown 46 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 15%
Researcher 7 15%
Student > Bachelor 5 11%
Student > Doctoral Student 3 6%
Lecturer 3 6%
Other 10 21%
Unknown 12 26%
Readers by discipline Count As %
Medicine and Dentistry 15 32%
Nursing and Health Professions 5 11%
Physics and Astronomy 5 11%
Agricultural and Biological Sciences 2 4%
Computer Science 1 2%
Other 4 9%
Unknown 15 32%